Advanced Classical Hodgkin Lymphoma clinical trials

Explore recruiting advanced classical hodgkin lymphoma clinical trials.

Recruiting advanced classical hodgkin lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Classical Hodgkin Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Denmark, Hungary, Italy, Belgium, Spain, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advanced Classical Hodgkin Lymphoma trials by city

Advanced Classical Hodgkin Lymphoma clinical trials

Recruiting advanced classical hodgkin lymphoma studies right now

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Also recruiting in Europe

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Advanced Classical Hodgkin Lymphoma trials by city

Other conditions